---
document_datetime: 2023-09-21 21:28:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tavneos-epar-all-authorised-presentations_en.pdf
document_name: tavneos-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8023915
conversion_datetime: 2025-12-24 00:45:11.985726
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                          |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|------------------------------------|
| EU/1/21/1605/001 | TAVNEOS           | 10 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 30 capsules                        |
| EU/1/21/1605/002 | TAVNEOS           | 10 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 180 capsules                       |
| EU/1/21/1605/003 | TAVNEOS           | 10 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 540 (3 x 180) capsules (multipack) |